Focusing on impact: Cochrane's Strategy to 2020 / Mark Wilson, CEO
-
Upload
cochranecollaboration -
Category
Documents
-
view
819 -
download
2
description
Transcript of Focusing on impact: Cochrane's Strategy to 2020 / Mark Wilson, CEO
1
Focusing on Impact: Cochrane’s Strategy to 2020
Mark Wilson
CEO, Cochrane
NETSCC, Southampton - 15th October 2014
A lot to be proud of …
The Cochrane Collaboration’s first 20 Years: an astonishing success
Contributed to the mainstream acceptance of ‘Evidence-Based Medicine’ and the acknowledged global leader in systematic reviews
Dramatic growth: contributors to Cochrane
3
• Today there are nearly 34,000 contributors in over 120 countries worldwide.
• In 2008 there were fewer than 10,000 authors; now more than 22,400 active registered authors of Cochrane Reviews.
Dramatic growth:Organisational infrastructure
4
• 14 regional Centres & 25 Branches
• 53 subject-based Review Groups
• 16 Methods Groups
• 12 thematic Fields & Networks
Dramatic growth inCochrane Review production
5
More than 8,500 full Cochrane reviews and protocols in the Cochrane Database of Systematic Reviews; and 725,000 entries in the Central Register of Controlled Trials published in The Cochrane Library
Dramatic growth inuse of Cochrane evidence
7
In 2013, 13.5 million abstract page views on The Cochrane Library published by Wiley; and another 4,181,131 page views of Cochrane Summaries.
Over 7.4 million full text downloads of Cochrane Reviews in 2013
2013 Impact factor: 5.959Five-year Impact factor: 6.706Total citations in 2013: 39,856 (more than the BMJ)One of the top 10 medical journals in the world
0
10
20
30
40
50
60
70
80
90
100
2008 2009 2010 2011 2012 2013
Pe
rce
nt
of
Gu
ide
line
s
Year of WHO Approval
Cochrane Involvement in WHO Guidelines (n = 101)
CochraneReviews
Teammember
GRADE
9
But Cochrane facesconsiderable challenges …
1. Complex Cochrane Review production process:
• Provides insufficient prioritisation of critical reviews needed/key answers required – ‘ad hoc’ production
• Increasingly long production process – can be unsatisfying for authors & slow and burdensome for Cochrane Review Groups
• Makes it unattractive for authors to keep reviews up-to-date or return to do another review
• Means the percentage of up-to-date reviews is falling • Leaves us exposed to competitors who can produce reviews
faster, more simply and efficiently, and with a better author experience.
Whilst unique, Cochrane is no longer alone
Academics & Other
Journals
Government-affiliated bodiesCommercial companies
Not-for-profit groups
“Anyone who produces, or who finds a way to make Systematic Reviews more digestible and more relevant to the audience, is in
competition with Cochrane”
11
Cochrane challenges
2. Knowledge Translation ‘Gap’; and an Improved ‘User Experience’ is needed for content presentation, delivery & usability:
• A need to improve the applicability and links of Cochrane evidence to health policy and practice
Reputational Audit showed us that generally Cochrane and our Reviews are seen as
the ‘gold standard’
Robust methodology
Comprehensive
studies
100% independent
Respected name
International reach
Passionate and
enthusiastic reviewers
13
“As a policy maker, to be able to say ‘this is the Cochrane Review on x,y,z’, is ticking a box to say ‘we’ve got the most exhaustive summary of the evidence possible’. It’s a reassurance”
Cochrane challenges
… but the Impact of our Reviews is reduced by our failure to translate them sufficiently
into the wider world
! Difficult to understand
! Lack ‘actionable’
output
! Not focussed on key
issues of the day
! Inflexible
! Avoid anything except
randomised trials
! Appearance of an
‘exclusive’ club
! Limited awareness
outside academics
15
“Sometimes these reviews come out and you say, ‘Okay – now what?’. It is about making the connection and prioritising reviews that are the most impactful.”
“It’s a very kind of elite medical review community that understands Cochrane.”
Cochrane challenges
16
Cochrane challenges
2. Knowledge Translation ‘Gap’; and an Improved ‘User Experience’ is needed on content presentation, delivery & usability:
• A need to improve the applicability and links of Cochrane evidence to health policy and practice
• ‘So what?’ for users – implications of the findings• Great progress made in recent years (Summary of Findings
Tables; Plain-Language Summaries; Cochrane Summaries; Cochrane App; ‘Anywhere Article’ launched in June 2014 improves readability/usability on mobile devices)
• But need to provide new tools, ways and products that allow users to find information they want more quickly and easily …
• A focus on the ‘end user’ not the Cochrane producer.
3. Are we really as globalas we think we are?
17
Africa1%
Oceania9%
Asia19%
Europe35%
North America32%
South America4%
Two-thirds of Cochrane Review downloads come from users in Europe and North America
Most authors come fromEurope and America
Most funding comes fromthe UK and USA
Content is primarily in English
18
Cochrane challenges
4. Incomplete Global Access to Cochrane Content:
• Inadequate provision of content in different languages prevents us reaching global audiences in their own languages – and therefore reduces our impact
5. Organisational and Resourcing:
• Complex structure overly reliant on individuals in positions of authority within their own organisations: creating challenges of accountability and generational change
• ‘Inward- facing’: creating problems for advocacy, marketing & communications, fundraising, partnership development and increasing membership
19
Cochrane challenges
5. Organisational and Resourcing:
• Unrealised potential of contributors from non-English speaking countries and L&MICs
• Squeezed research budgets worldwide affecting infrastructural funding to Cochrane groups
• Over reliance on income from sales of The Cochrane Library as publishing moves towards Open Access
Responding to the Challenges:
Strategy to 2020
Vision Mission
Our Vision is a world of improved healthwhere decisions about health and health care are informed by high-
quality, relevant and up-to-date synthesized research evidence.
Our Mission is to promote evidence-informed
health decision-making by producing high-quality, relevant, accessible systematic reviews and
other synthesized research evidence.
Vision Mission Goals
Goal 1: Producing Evidence - To produce high-quality, relevant, up-to-date systematic reviews and other synthesized research evidence to inform health decision-making
Goal 2: Accessible Evidence - To make Cochrane evidence accessible and useful to everybody, everywhere in the world
Strategy to 2020
Goal 3: Advocating for Evidence - To make Cochrane the ‘home of evidence’ to inform health decision-making, build greater recognition of our work, and become the leading advocate for evidence-informed health care.
Goal 4: Building an Effective & Sustainable Organisation - To be a diverse, inclusive and transparent international organisation that effectively harnesses the enthusiasm and skills of our contributors, is guided by our principles, governed accountably, managed efficiently and makes optimal use of its resources.
Objectives
High quality
Up to date
Relevant
Wide coverage
Pioneering Methods
Efficient production
(2)
Objective 1 of 7:
We will continue to develop and implement comprehensive quality
assurance mechanisms for editorial and methodological
standards throughout our production and updating
processes.
Goal One: Producing Evidence
Strategy to 2020 Vision Mission Goals Objectives
Strategy to 2020 Vision Mission Goals Objectives
Goal One
7 Objectives
High quality
Up to date
Relevant
Wide coverage
Pioneering Methods
Efficient production
(2)
Goal Three
8 Objectives
Global Profile
The ‘Home of Evidence’
(2)
Global Advocate
(3)
Global Partner
Global Impact Goal Four
7 Objectives
Inclusive & Open
Global &
Diverse
Financially
Strong
Efficiently Run
Investing in
People
Transparently
Governed
Environmentally Respons
ible
Goal Two
6 Objectives
User-Centred
(3)
Open Access
Accessible Language
Multi-lingual
Vision Mission Goals Objectives Targets
2014 Target: High Quality
Goal One: Producing Evidence
Objectives
High quality
Up to date
Relevant
Wide coverage
Pioneering Methods
Efficient production Create a prioritised set of the existing
MECIR standards with the aim of achieving 100% compliance to them for
new Cochrane Systematic Reviews.
26
Delivering Strategy to 2020
Vision Mission Goals Objectives Targets
4 Goals
28 Objectives
21 Targets for 2014
29
Goal 1: Producing EvidenceTo produce high-quality, relevant, up-to-date systematic
reviews and other synthesized research evidence to inform health decision-making
Cochrane’s production challenge:
“dedicated to delivering evidence more quickly and
effectively, without compromising on quality ”
Create a prioritised set of the existing MECIR standards with the aim of
achieving 100% compliance to them for new Cochrane Systematic Reviews.
• Quality assurance process has been highly successful and continued due to demand
• An audit process has now also started which will lead to the development of the subset
Vision Mission Goals Objectives Targets
Target 1.2: MECIR subset
Goal One: Producing Evidence
Objectives
High quality
Up to date
Relevant
Wide coverage
Pioneering Methods
Efficient production
Objectives
High quality
Up to date
Relevant
Wide coverage
Pioneering Methods
Efficient production
Vision Mission Goals Objectives Targets
Improve production processes by implementing a web-based author
support tool
• Decision made on preferred provider following RFP process
• Implementation work will start immediately with anticipated full launch in Spring 2015
Target 1.3.i: Author Support Tool
Goal One: Producing Evidence
Goal 2: Accessible EvidenceTo make Cochrane evidence accessible and useful to
everybody, everywhere in the world
Cochrane: Focused on Users –Focused on Impact
“What we produce only has value to the extent that it is
meaningful to people making decisions about health.”
Vision Mission Goals Objectives Targets
Objectives
User-Centred
Open Access
Accessible Language
Multi-lingual
Develop a roadmap for achieving universal open access to new and
updated Cochrane Systematic Reviews by the end of 2016.
• Significant work has been undertaken to scope out possible models for Cochrane
• A recommendation to explore two specific models in detail is being considered by the Steering Group
• Open Access roadmap will be in place in early 2015
Target 2.4: Open Access Roadmap
Goal Two: Accessible Evidence
Vision Mission Goals Objectives Targets
Objectives
User-Centred
Open Access
Accessible Language
Multi-lingual
Goal Two: Accessible Evidence
Finalise strategy, establish an integrated translation management system and introduce key digital content and multi-lingual portals in French, Spanish and three other languages.
• Strategy approved and translation co-ordinator appointed
• Translation Management System adopted and already in use by 12 language teams –with many more to come
• €400,000 raised for translation into German & East European languages
• Multi-lingual web sites to be launched in 2015
Target 2.6: Translation Strategy
Vision Mission Goals Objectives Targets
Objectives
User-Centred
Open Access
Accessible Language
Multi-lingual
Learning As We Go
Gather systematic data and improve our understanding of end-user
experience and need; and establish a framework for ongoing reassessment.
• Critical to informing our future development
• Larger scope than anticipated, so we have deferred the deadline to ensure it is done properly
Target 2.1: User Experience Review and Framework
Goal 3: Advocating for EvidenceTo make Cochrane the ‘home of evidence’ to inform
health decision-making, build greater recognition of our work, and become the leading advocate for evidence-
informed health care.
Cochrane – Engaging with the World
“Transform Cochrane to be truly Global, working more in partnership with others, and using our position to advocate and speak out for our
goals. ”
Vision Mission Goals Objectives Targets
Objectives
Global Profile
The ‘Home of Evidence’
(x2)
Global Advocate
(x3)
Global Partner
Global Impact
Goal Three: Advocating for Evidence
Create a coherent Cochrane brand across all content.
• New logo approved• Full launch of new brand on
schedule for Jan 2015
Target 3.1: Coherent Brand
Vision Mission Goals Objectives Targets
Objectives
Global Profile
The ‘Home of Evidence’
Global Advocate
Global Partner
Global Impact
Goal Three: Advocating for Evidence
Identify and establish partnerships with three to five international
strategic stakeholders to advance evidence-informed health decision-
making.
• GIN and Wikipedia partnerships formed
• Campbell Collaboration partnership imminent
• Will begin working on new Cochrane-WHO work plan 2015-
Target 3.2: Establish 3-5 strategic partnerships
Objectives to 2020:
Inclusive and Open
Financially Strong
Investing in People
Environmentally Responsible
Goal 4: Building an Effective & Sustainable OrganisationTo be a diverse, inclusive and transparent international organisation that effectively harnesses the enthusiasm
and skills of our contributors, is guided by our principles, governed accountably, managed efficiently and makes
optimal use of its resources.
Global and Diverse
Efficiently Run
Transparently Governed
Reputational Audit asked: What is a typical ‘Cochrane persona’?
Academic
Unique
Volunteer
British heart
Passionate
Rigorous
Respected
Independent
Out-dated
Rigid
Obsessive
Exclusive
Passionate but seen better days!
Vision Mission Goals Objectives Targets
Objectives
Inclusive & Open
Global & Diverse
Financially Strong
Efficiently Run
Investing in People
Transparently
Governed
Environmentally Responsi
ble
Goal Four: Building an Effective and Sustainable Organisation
Introduce a Cochrane Membership scheme.
• Aiming to make Cochrane open and accessible to anyone who subscribes to our mission
• We want to launch the membership scheme by the end of 2015 – preferably at Vienna Colloquium
Target 4.1: Membership Scheme
Vision Mission Goals Objectives Targets
Objectives
Inclusive & Open
Global & Diverse
Financially Strong
Efficiently Run
Investing in People
Transparently
Governed
Environmentally Responsi
ble
Goal Four: Building an Effective and Sustainable Organisation
Develop, and begin implementation of, an inter-professional and inclusive
training and professional development strategy.
• Training strategy approved – Sept 2014 - £3m over 4 years
• Implementation to start by the end of the year
Target 4.2: Training Strategy
Vision Mission Goals Objectives Targets
Objectives
Inclusive & Open
Global & Diverse
Financially Strong
Efficiently Run
Investing in People
Transparently
Governed
Environmentally Responsi
ble
Goal Four: Building an Effective and Sustainable Organisation
We will increase the transparency of the organisation’s governance and improve the opportunities for any
contributor to participate in governing …
• Cochrane Steering Group (CSG) to be reformed – non-executive directors to be introduced
• Review of governance and accountability of all Cochrane Groups in 2015
Target 4.3: Governance Review
Vision Mission Goals Objectives Targets
Objectives
Inclusive & Open
Global & Diverse
Financially Strong
Efficiently Run
Investing in People
Transparently
Governed
Environmentally Responsi
ble
Goal Four: Building an Effective and Sustainable Organisation
Review and adjust the structure and functions of the global network of
Cochrane groups
• Cochrane Review Group Review already started in 2014
• Reviews of Centres & Branches, Fields, Consumers & Methods Groups to follow in 2015
Target 4.4: Structure & Function Review
Focusing on Impact:Cochrane’s Path to 2020
• Cochrane continuing to grow– Nearly 35,000 registered volunteers; with over 8,000 active in the last six
months
– Five new Cochrane branches opened in 2014: Japan, Malaysia, Mexico, Portugal, Poland; and French Satellite of the Musculoskeletal CRG opened
• Cochrane Library Sales– Record year in 2013-14 for sales revenues and royalties
– Sales on target - 5% increase in 2014 projected;
• Strong financial position– Excellent 2013-14 results: £1.2m operating surplus;
– Reserves at record £7.2m – but we’ll need it: strategic investments to be made (‘Game Changers’) & OA transition to be managed
• Substantial challenges - Strategy 2020 will address them46
Focusing on Impact:Cochrane’s Path to 2020
We want better healthcare decision making to create a world of improved health …
by producing and promoting the use of high-quality evidence-informed research …
then making this information accessible & usable to everyone who needs it.